Clinical trial amendments frequently introduce delays, increased costs, and administrative burden, with eligibility criteria being the most commonly amended component. We introduce \textit{eligibility criteria amendment prediction}, a novel NLP task that aims to forecast whether the eligibility criteria of an initial trial protocol will undergo future amendments. To support this task, we release AMEND++, a benchmark suite comprising two datasets: AMEND, which captures eligibility-criteria version histories and amendment labels from public clinical trials, and AMEND_LLM, a refined subset curated using an LLM-based denoising pipeline to isolate substantive changes. We further propose Change-Aware Masked Language Modeling (CAMLM), a revision-aware pretraining strategy that leverages historical edits to learn amendment-sensitive representations. Experiments across diverse baselines show that CAMLM consistently improves amendment prediction, enabling more robust and cost-effective clinical trial design.
@article{arxiv.2601.06300,
title = {$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials},
author = {Trisha Das and Mandis Beigi and Jacob Aptekar and Jimeng Sun},
journal= {arXiv preprint arXiv:2601.06300},
year = {2026}
}